We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.21% |
| 2 | Technology | 14.44% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 8.99% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NNN REIT
NNN
$9.38B
| $112M | 0.28% |
2,613,570
-58,165
| -2% | -$2.5M |
|
77
Sarepta Therapeutics
SRPT
$1.62B
| $111M | 0.27% |
964,947
+148,025
| +18% | +$19.1M |
|
78
Bank of America
BAC
$432B
| $110M | 0.27% |
3,832,314
-41,089
| -1% | -$1.17M |
|
79
Public Service Enterprise Group
PEG
$39.1B
| $108M | 0.27% |
1,719,543
-6,568
| -0.4% | -$410K |
|
80
Accenture
ACN
$108B
| $107M | 0.27% |
346,826
-78,993
| -19% | -$23M |
|
81
New Fortress Energy
NFE
$95M
| $106M | 0.26% |
3,974,400
| – | – |
|
82
Agnico Eagle Mines
AEM
$70.4B
| $103M | 0.26% |
2,058,712
+669,236
| +48% | +$36.2M |
|
83
Canadian Imperial Bank of Commerce
CM
$107B
| $102M | 0.25% |
2,395,760
+434,784
| +22% | +$18.4M |
|
84
IBM
IBM
$214B
| $101M | 0.25% |
753,522
+97,606
| +15% | +$12.6M |
|
85
Bristol-Myers Squibb
BMY
$130B
| $99.9M | 0.25% |
1,561,618
+29,026
| +2% | +$1.95M |
|
86
Planet Fitness
PLNT
$4.46B
| $99.7M | 0.25% |
1,477,915
-106,076
| -7% | -$7.6M |
|
87
Chipotle Mexican Grill
CMG
$43.8B
| $99.2M | 0.25% |
2,319,500
+288,050
| +14% | +$11.4M |
|
88
MSCI
MSCI
$42.4B
| $95.9M | 0.24% |
204,406
+1,036
| +0.5% | +$505K |
|
89
FedEx
FDX
$73.3B
| $95M | 0.24% |
383,032
+26,307
| +7% | +$6.02M |
|
90
Chevron
CVX
$384B
| $94.2M | 0.23% |
598,767
+292,800
| +96% | +$46.9M |
|
91
VICI Properties
VICI
$29.9B
| $91.7M | 0.23% |
2,916,908
-67,929
| -2% | -$2.18M |
|
92
Spotify
SPOT
$106B
| $90.8M | 0.23% |
565,708
-39,869
| -7% | -$5.78M |
|
93
Veeva Systems
VEEV
$33.8B
| $90.3M | 0.22% |
456,541
-38
| -0% | -$6.93K |
|
94
Merck
MRK
$326B
| $90.2M | 0.22% |
781,657
+116,786
| +18% | +$13.3M |
|
95
Capital One
COF
$130B
| $88.7M | 0.22% |
810,956
+24,274
| +3% | +$2.43M |
|
96
HEICO Corp
HEI
$49.5B
| $88.1M | 0.22% |
497,886
+135,384
| +37% | +$22.8M |
|
97
Blackrock
BLK
$170B
| $87.7M | 0.22% |
126,889
-274
| -0.2% | -$184K |
|
98
JPMorgan Chase
JPM
$927B
| $86.6M | 0.21% |
595,173
+142,563
| +31% | +$19.6M |
|
99
Humana
HUM
$43.6B
| $85.6M | 0.21% |
191,355
+19,322
| +11% | +$9.73M |
|
100
Marathon Petroleum
MPC
$90.8B
| $85.4M | 0.21% |
732,187
+31,803
| +5% | +$3.7M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.